STAAR SURGICAL CO - Common Stock, par value $0.01 per share (STAA)

Historical Holders from Q1 2014 to Q3 2025

Symbol
STAA on Nasdaq
CUSIP
852312305
Type / Class
Equity / Common Stock, par value $0.01 per share
Shares outstanding
49.8M
All holders as of September 30, 2025
Q3 2025
Total 13F shares, excl. options
50.5M
Holdings value
$1.36B
% of all portfolios
0.01%
Grand Portfolio weight change
+0%
Number of holders
190
Number of buys
108
Number of sells
-97
Average Value change %
+0%
Average buys %
+0.005%
Average sells %
-0.002%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of STAAR SURGICAL CO - Common Stock, par value $0.01 per share (STAA)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BROADWOOD PARTNERS, L.P. 30.2% +10.4% $418M $41.7M 15M +11.1% Neal C. Bradsher Nov 20, 2025
BlackRock, Inc. 15% -10% $115M -$12.8M 7.4M -9.98% BlackRock, Inc. Mar 31, 2025
VANGUARD GROUP INC 8.86% $85.8M 4.39M The Vanguard Group Jun 30, 2025
ARMISTICE CAPITAL, LLC 6.08% $46.7M 3M Armistice Capital, LLC Mar 31, 2025
Yunqi Capital Ltd 5.1% 0% $67.2M 2.5M 0% Yunqi Capital Limited Oct 31, 2025
Soleus Capital Master Fund, L.P. 1% -84% $13.4M -$55.4M 500K -80.5% Soleus Capital Master Fund, L.P. Sep 30, 2025

Institutional Holders of STAAR SURGICAL CO - Common Stock, par value $0.01 per share (STAA)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 50.5M $1.36B +$3.13M $26.87 190
2025 Q2 53.8M $903M +$23M $16.78 166
2025 Q1 52.2M $921M +$41.4M $17.63 183
2024 Q4 48.3M $1.17B -$40.2M $24.29 209
2024 Q3 49M $1.82B +$30.1M $37.15 236
2024 Q2 47.1M $2.24B -$8.82M $47.61 220
2024 Q1 48.4M $1.85B -$121M $38.28 196
2023 Q4 129K $4.03M -$754K $31.21 4
2023 Q3 52.8M $2.12B +$110M $40.18 208
2023 Q2 49.7M $2.61B +$49M $52.57 234
2023 Q1 48.1M $3.08B +$181M $63.95 240
2022 Q4 46.2M $2.24B -$65.5M $48.54 258
2022 Q3 46.6M $3.29B +$26.5M $70.55 286
2022 Q2 46.6M $3.3B +$134M $70.93 256
2022 Q1 44.6M $3.56B +$126M $79.91 254
2021 Q4 42.7M $3.9B +$49.3M $91.30 264
2021 Q3 42.1M $5.41B -$12.4M $128.53 282
2021 Q2 41.7M $6.36B -$18M $152.50 276
2021 Q1 42.5M $4.48B +$266M $105.41 220
2020 Q4 39.5M $3.13B +$3.93M $79.22 187
2020 Q3 39.7M $2.25B -$98.8M $56.56 173
2020 Q2 41.3M $2.54B -$21.7M $61.54 188
2020 Q1 41.7M $1.34B -$49M $32.26 157
2019 Q4 42M $1.48B +$39.1M $35.17 159
2019 Q3 41.2M $1.06B +$20.3M $25.78 147
2019 Q2 40.5M $1.19B +$45.5M $29.38 152
2019 Q1 39.3M $1.34B -$10.6M $34.19 183
2018 Q4 39.6M $1.26B +$20.4M $31.91 176
2018 Q3 37.5M $1.8B +$158M $48.00 190
2018 Q2 34.9M $1.08B +$60.8M $31.00 147
2018 Q1 32.8M $485M +$4.24M $14.80 98
2017 Q4 32.5M $504M +$8.82M $15.50 103
2017 Q3 32M $398M +$6.4M $12.45 87
2017 Q2 31.5M $340M +$5.54M $10.80 83
2017 Q1 31M $303M +$22.5M $9.80 77
2016 Q4 31.1M $338M +$10.8M $10.85 78
2016 Q3 29.8M $280M -$1.2M $9.40 71
2016 Q2 29.8M $164M +$62.3K $5.51 70
2016 Q1 30.1M $223M -$3.1M $7.39 75
2015 Q4 30.6M $219M -$7.36M $7.14 73
2015 Q3 31.4M $244M -$2.3M $7.76 71
2015 Q2 31.4M $304M +$9.43M $9.66 78
2015 Q1 31.1M $231M +$2.39M $7.43 71
2014 Q4 30.2M $275M -$6.04M $9.11 80
2014 Q3 30.6M $326M -$21.2M $10.63 82
2014 Q2 31.4M $527M +$10.9M $16.80 104
2014 Q1 30.4M $572M +$23M $18.80 101